Tagala, Pablito L.

HRN: 23-01-53  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2023
CEFTAZIDIME 1GM (VIAL)
05/10/2023
05/17/2023
IV
1gm
Q8
CAP-MR
Waiting Final Action 
05/14/2023
CLARITHROMYCIN 500MG (CAP)
05/14/2023
05/20/2023
PO
500mg
BID
Pneumonia
Waiting Final Action 
05/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/19/2023
05/19/2023
IV
4.5g
Now
Community Acquired Pneumonia - Moderate Risk
05/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/19/2023
05/25/2023
IV
2.25g
Q8H
Community Acquired Pneumonia - Moderate Risk

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: